Main menu button

News

Carlsquare advised XPLN's shareholders on the sale of XPLN to Similarweb
12 Mar 2026
Carlsquare advised XPLN's shareholders on the sale of XPLN to Similarweb
Deal News
DMEA 2026 Warm-up
05 Mar 2026
DMEA 2026 Warm-up
Events
Carlsquare acted as the exclusive debt advisor of enua Pharma on the structuring of a growth financing package
04 Mar 2026
Carlsquare acted as the exclusive debt advisor of enua Pharma on the structuring of a growth financing package
Deal News
Carlsquare advised Aspria on the sale to David Lloyd Leisure, a portfolio company of TDR Capital
02 Mar 2026
Carlsquare advised Aspria on the sale to David Lloyd Leisure, a portfolio company of TDR Capital
Deal News
Equity Research ALM Equity Q4 2025: Higher profit with a thousand housing starts per year
02 Mar 2026
Equity Research ALM Equity Q4 2025: Higher profit with a thousand housing starts per year
Equity Research ALM Equity
Equity research Enrad, Q4 2025: A Sweden push to accelerate growth
01 Mar 2026
Equity research Enrad, Q4 2025: A Sweden push to accelerate growth
Equity Research Enrad
Equity research Enrad, Q4 2025: Soft sales but order pipeline intact
27 Feb 2026
Equity research Enrad, Q4 2025: Soft sales but order pipeline intact
Equity Research Enrad
Equity research Zinzino Q4 2025: Healthy scalability
27 Feb 2026
Equity research Zinzino Q4 2025: Healthy scalability
Equity Research Zinzino
Equity Research ALM Equity, Q4 2025: Increased cash and improved prospects
26 Feb 2026
Equity Research ALM Equity, Q4 2025: Increased cash and improved prospects
Equity Research ALM Equity
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
25 Feb 2026
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
Equity Research Immunovia
Equity research Zinzino Q4 2024: First impression - Margins significantly above our expectations
25 Feb 2026
Equity research Zinzino Q4 2024: First impression - Margins significantly above our expectations
Equity Research Zinzino
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
24 Feb 2026
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
Equity Research Immunovia
Equity research Enrad, Q4 2025: A profit for the quarter may be on the cards
22 Feb 2026
Equity research Enrad, Q4 2025: A profit for the quarter may be on the cards
Equity Research Enrad
Equity research Viva Wine Group Q4 2025: Delta profit surprise raises spirits
20 Feb 2026
Equity research Viva Wine Group Q4 2025: Delta profit surprise raises spirits
Equity Research Viva Wine Group
Equity research Angler Gaming, Q4 2025: A year defined by margin improvement
20 Feb 2026
Equity research Angler Gaming, Q4 2025: A year defined by margin improvement
Equity Research Angler Gaming
Robotics & Smart Manufacturing Conference
19 Feb 2026
Robotics & Smart Manufacturing Conference
Events
Equity research Viva Wine Group Q4 2025: First impression - Better than expected as Delta surprises
19 Feb 2026
Equity research Viva Wine Group Q4 2025: First impression - Better than expected as Delta surprises
Equity Research Viva Wine Group
Equity research Angler Gaming, Q4 2025: Another quarter with margins expansion
19 Feb 2026
Equity research Angler Gaming, Q4 2025: Another quarter with margins expansion
Equity Research Angler Gaming
Carlsquare acted as exclusive debt advisor to EOS Immobilien GmbH on the refinancing of its residential real estate portfolio
18 Feb 2026
Carlsquare acted as exclusive debt advisor to EOS Immobilien GmbH on the refinancing of its residential real estate portfolio
Deal News
Equity research White Pearl Technology Group: A growth and profitability engine at a discount
18 Feb 2026
Equity research White Pearl Technology Group: A growth and profitability engine at a discount
Equity Research White Pearl Technology Group